[ad_1]
northInitial clinical trials of the vaccine have been shown to elicit an immune response in volunteers, according to a study being carried out by scientists at the University of Bristol in the UK, The Sun newspaper reports.
Typically, vaccines use a weakened form of the virus, or small amounts, in their formulation; however, the innovative Oxford vaccine makes the body part of the virus itself.
The researchers found that this new technique works for the new coronavirus.
The study used cells in the laboratory and detected that the vaccine instructs the protein of COVID-19, whose cells then replicate thousands of times, producing them in large quantities.
Due to this process, the system immune of people are prepared to recognize the disease and combatwithout making people sick.
Professor David Matthews, School of Cellular and Molecular Medicine (CMM), from the University of Bristol, who led the study, said: “Until now, technology has not been able to give very clear answers, but we know that this vaccine is doing everything we expected and that it works perfectly. This is the only good one. news in our fight against COVID-19-19 “.
Sarah Gilbert, in charge of clinical trials at Oxford University, said: “This study confirms that large amounts of the new spike protein coronavirus they are produced very precisely, and this is very promising in explaining the success of the vaccine in inducing a strong immune response. ”
The death of the volunteer
The doctor and volunteer João Pedro Ugly died of complications while participating in clinical trials. It is believed that the doctor will not have received the vaccine, but a benign placebo.
However, testing of the vaccine is already underway again.
To date, the AZD1222 vaccine has been given to 18,000 people in clinical trials, which are underway in the UK. Africa South, United States and Brazil.
The Oxford vaccine and AstraZeneca remains the great hope of being able to stop the spread of COVID-19-19 worldwide.
Always be the first to know.
Follow the chosen site for the fourth consecutive year Consumer Choice.
Download our free app.
[ad_2]
